行为经济学和高血压的药物坚持:一个随机临床试验
John A Dodson1, Samrachana Adhikari1, Antoinette M Schoenthaler1
1NYU Grossman School of Medicine, New York, New York, USA.
Journal of the American College of Cardiology
|December 11, 2025
概括
使用激励彩票的移动健康 (mHealth) 干预措施使高血压患者的药物坚持增加了一倍,但没有显著降低缩血压 (SBP). 这项研究强调了移动健康在改善弱势群体遵守规则方面的潜力.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 数字健康数字健康
背景情况:
- 不坚持服用抗高血压药物是一个重大挑战,特别是在脆弱人群中.
- 移动健康 (mHealth) 干预措施有望改善药物坚持,但需要进一步测试.
研究的目的:
- 评估基于mHealth的激励彩票干预措施对高血压患者的药物坚持和缩血压 (SBP) 的有效性.
- 评估行为经济学试验对提高血压调节 (BETTER-BP) 对安全网诊所人群中的遵守和SBP的影响.
主要方法:
- 一个随机试验 (BETTER-BP) 涉及400名患有高血压和不良坚持在纽约市3个安全网诊所的成年人.
- 参与者通过短信或标准护理接受了mHealth激励彩票,并在6个月内被动监测遵守.
- 主要终点包括SBP的变化和足够的药物坚持 (≥80%的坚持时间) 在6个月.
主要成果:
- 与对照组相比,干预组显示出明显更高的充分遵守率 (71%对34%).
- 在6个月后,干预组和对照组之间没有观察到平均SBP减少的显著差异.
- 在6至12个月的组中,坚持率在6至12个月的组之间是相似的.
结论:
- 在BETTER-BP mHealth干预中,在多样化的安全网人口中,有效地增加了药物坚持的两倍.
- 尽管依从性改善,但干预措施在6个月后并没有导致SBP显著减少.
- 移动健康干预措施有可能提高药物坚持,但需要进一步的研究来优化它们对血压等临床结果的影响.
更多相关视频
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
16.6K
05:10Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
875
相关概念视频
Hypertension IV: Drug Therapy and Lifestyle Modifications
575
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
575
Drug Therapy
232
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
232
Hypertension V: Nursing Management
336
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
336
Hypertension III: Clinical Manifestations and Diagnostic Studies
442
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
442
Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K
Atherosclerosis III: Management
293
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293
